Back to Trades
Grant4
HAEMONETICS CORP
HAE
Total Value
$544.9K
Company Information
- Company Name
- HAEMONETICS CORP
- Ticker Symbol
- HAE
- CIK
- 0000313143
Insider Information
- Role
- President & CEO, Director
- Location
- BOSTON, MA
DirectorOfficer
Filing Details
- Filing Date
- May 19, 2026
- Transaction Date
- May 15, 2026
- Accession Number
- 0000313143-26-000042
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | 9,681 | $56.29 | Tax Withholding | $544.9K |
| May 15, 2026 | Common Stock | 78,344 | — | Grant/Award | — |
Footnotes
- (F1)Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
- (F2)This number includes unvested RSUs previously reported as well as 497 shares purchased by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026.
- (F3)The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant.
- (F4)Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.